Barrington Research Reiterates “Outperform” Rating for Henry Schein (NASDAQ:HSIC)

Henry Schein (NASDAQ:HSIC)‘s stock had its “outperform” rating reiterated by Barrington Research in a note issued to investors on Friday, Benzinga reports. They presently have a $82.00 price objective on the stock. Barrington Research’s price objective indicates a potential upside of 14.83% from the stock’s previous close.

Several other research firms also recently commented on HSIC. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. JPMorgan Chase & Co. reduced their target price on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. UBS Group lowered their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Robert W. Baird cut their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Finally, Piper Sandler reissued an “overweight” rating and issued a $86.00 target price on shares of Henry Schein in a research note on Friday, June 21st. One analyst has rated the stock with a sell rating, six have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $77.10.

Henry Schein Price Performance

NASDAQ HSIC traded down $1.13 on Friday, hitting $71.41. The company had a trading volume of 153,945 shares, compared to its average volume of 1,323,032. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. The company’s fifty day moving average price is $69.77 and its 200-day moving average price is $70.42. The company has a market capitalization of $9.14 billion, a PE ratio of 24.13, a PEG ratio of 1.88 and a beta of 0.86. Henry Schein has a 12-month low of $60.01 and a 12-month high of $82.63.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. The business had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company’s quarterly revenue was up .0% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.31 earnings per share. As a group, analysts predict that Henry Schein will post 4.75 earnings per share for the current year.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.14% of the stock is owned by corporate insiders.

Institutional Trading of Henry Schein

Hedge funds have recently modified their holdings of the stock. Sanctuary Advisors LLC purchased a new position in Henry Schein in the second quarter worth approximately $351,000. Brandes Investment Partners LP increased its holdings in shares of Henry Schein by 35.0% in the 2nd quarter. Brandes Investment Partners LP now owns 7,332 shares of the company’s stock valued at $470,000 after acquiring an additional 1,900 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in Henry Schein by 84.0% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 3,189 shares of the company’s stock worth $204,000 after purchasing an additional 1,456 shares in the last quarter. Scientech Research LLC grew its position in shares of Henry Schein by 271.6% in the 2nd quarter. Scientech Research LLC now owns 30,307 shares of the company’s stock valued at $1,943,000 after buying an additional 22,152 shares during the last quarter. Finally, Lighthouse Investment Partners LLC acquired a new stake in shares of Henry Schein during the second quarter worth about $2,999,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.